Format

Send to

Choose Destination
J Tradit Complement Med. 2013 Oct;3(4):256-62. doi: 10.4103/2225-4110.119734.

Concurrent Use of Conventional Drugs with Chinese Herbal Products in Taiwan: A Population-based Study.

Author information

1
Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan. ; Department of Family Medicine, Taipei City Hospital, Yang-Ming Branch, Taipei, Taiwan.
2
Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan. ; Department of Chinese Medicine, Taipei City Hospital, Yang-Ming Branch, Taipei, Taiwan.
3
Institute of Occupational Medicine and Industrial Hygiene, College of Public Health, National Taiwan University, Taipei, Taiwan. ; Department of Public Health, National Taiwan University, College of Public Health, Taipei, Taiwan.
4
Department of Public Health, National Cheng Kung University College of Medicine, Tainan City, Taiwan.

Abstract

The increased use of Chinese herbal products (CHPs) worldwide has raised the concern of herb-drug interactions. The aim of this study was to determine the prevalence and utilization patterns of concurrent use of conventional drugs and CHPs in Taiwan. The usage and frequency of services in the co-prescription of a CHP and a conventional drug were evaluated. Subjects were recruited from a simple random sample of 1,000,000 subjects from over 22 million beneficiaries of the National Health Insurance in 2007. The logistic regression method was employed to estimate the odds ratios (ORs) for the co-prescription of a CHP and a conventional drug (CH + D) and a conventional drug alone (D-alone). The prevalence of the CH + D was 14.1%. Females, regular salary earners, and elderly (65 years and above) were more likely to consume a CHP and a conventional drug concurrently. Painkillers, especially acetaminophen, and anti-cough medicines were the top two conventional drugs that were most frequently co-prescribed with a CHP. Anti-cough medication is the most common conventional drug co-prescribed with CHP, after painkillers. We recommend that safety issues be investigated in future research and integrating both healthcare technologies may be beneficial for the overall health and quality of life of patients.

KEYWORDS:

Chinese herbal product; Co-prescription; Conventional drug; Herb–drug interaction

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center